MeCP2 controls hippocampal brain-derived neurotrophic factor expression via homeostatic interactions with microRNA‑132 in rats with depression

Su,Meilei; Hong,Jun; Zhao,Yongzhi; Liu,Shuai; Xue,Xiang

doi:10.3892/mmr.2015.4104

MeCP2 controls hippocampal brain-derived neurotrophic factor expression via homeostatic interactions with microRNA‑132 in rats with depression

Authors:
- Meilei Su
- Jun Hong
- Yongzhi Zhao
- Shuai Liu
- Xiang Xue
View Affiliations

Affiliations: Department of Psychology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China
Published online on: July 20, 2015 https://doi.org/10.3892/mmr.2015.4104
Pages: 5399-5406

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Major depressive disorder (MDD) is a considerable public health concern, which affects patients worldwide. MDD is associated with psychosocial impairment, poor quality of life, and significant disability, morbidity and mortality. Stress is a major factor in depression, which impairs the structural and functional plasticity of the hippocampus. Previous studies have demonstrated that chronic unpredictable mild stress is able to downregulate the expression of brain‑derived neurotrophic factor (BDNF) and methyl‑CpG‑binding protein 2 (MeCP2), and alter the expression levels of certain microRNAs (miR). The aim of the present study was to investigate the regulatory association between BDNF, MeCP2 and miR-132 in an animal model of chronic stress‑induced depression. ELISA, western blot and qPCR were used to detect the expression levels of BDNF, MeCP2 and miR-132 in the peripheral blood samples of patients with MDD and in the hippocampi of depressed animals. In addition, a dual luciferase reporter gene system was used to determine whether miR-132 directly targets BDNF or MeCP2. The present study demonstrated that, as compared with normal subjects, miR‑132 expression was increased in the peripheral blood samples of patients with MDD, whereas the expression of MeCP2 and BDNF was decreased; thus, the expression levels of MeCP2 and BDNF were negatively correlated with those of miR‑132. In addition, in an animal model of chronic stress‑induced depression, increased expression levels of miR‑132, and decreased levels of MeCP2 and BDNF were detected in the hippocampi. Furthermore, knockdown of MeCP2 expression in primary hippocampal neurons increased the expression of miR‑132 and decreased the expression levels of BDNF. The results of the present study demonstrated that miR‑132 may directly target MeCP2, but not BDNF, and control its expression at the transcriptional and translational level. miR‑132 was also shown to negatively regulate BDNF expression. The reduced expression levels of BDNF, as induced by MeCP2 knockdown, were enhanced by miR‑132 mimics, and were rescued by miR‑132 inhibitors. These results suggested that homeostatic interactions between MeCP2 and miR‑132 may regulate hippocampal BDNF levels, which may have a role in the pathogenesis of MDD.

View Figures

View References

1	Dwivedi Y: Emerging role of microRNAs in major depressive disorder: Diagnosis and therapeutic implications. Dialogues Clin Neurosci. 16:43–61. 2014.PubMed/NCBI
2	Mouillet-Richard S, Baudry A, Launay JM and Kellermann O: MicroRNAs and depression. Neurobiol Dis. 46:272–278. 2012. View Article : Google Scholar : PubMed/NCBI
3	Sala M, Perez J, Soloff P, Ucelli di Nemi S, Caverzasi E, Soares JC and Brambilla P: Stress and hippocampal abnormalities in psychiatric disorders. Eur Neuropsychopharmacol. 14:393–405. 2004. View Article : Google Scholar : PubMed/NCBI
4	Li M, Fu Q, Li Y, Li S, Xue J and Ma S: Emodin opposes chronic unpredictable mild stress induced depressive-like behavior in mice by upregulating the levels of hippocampal glucocorticoid receptor and brain-derived neurotrophic factor. Fitoterapia. 98:1–10. 2014. View Article : Google Scholar : PubMed/NCBI
5	Maripuu M, Wikgren M, Karling P, Adolfsson R and Norrback KF: Relative hypo- and hypercortisolism are both associated with depression and lower quality of life in bipolar disorder: A cross-sectional study. PLoS One. 9:e986822014. View Article : Google Scholar : PubMed/NCBI
6	Réus GZ, Abelaira HM, Stringari RB, Fries GR, Kapczinski F and Quevedo J: Memantine treatment reverses anhedonia, normalizes corticosterone levels and increases BDNF levels in the prefrontal cortex induced by chronic mild stress in rats. Metab Brain Dis. 27:175–182. 2012. View Article : Google Scholar : PubMed/NCBI
7	Li YJ, Xu M, Gao ZH, Wang YQ, Yue Z, Zhang YX, Li XX, Zhang C, Xie SY and Wang PY: Alterations of serum levels of BDNF-related miRNAs in patients with depression. PLoS One. 8:e636482013. View Article : Google Scholar : PubMed/NCBI
8	Bai M, Zhu X, Zhang Y, Zhang S, Zhang L, Xue L, Yi J, Yao S and Zhang X: Abnormal hippocampal BDNF and miR-16 expression is associated with depression-like behaviors induced by stress during early life. PLoS One. 7:e469212012. View Article : Google Scholar : PubMed/NCBI
9	Bahi A, Chandrasekar V and Dreyer JL: Selective lentiviral-mediated suppression of microRNA124a in the hippocampus evokes antidepressants-like effects in rats. Psychoneuroendocrinology. 46:78–87. 2014. View Article : Google Scholar : PubMed/NCBI
10	O'Connor RM, Grenham S, Dinan TG and Cryan JF: microRNAs as novel antidepressant targets: Converging effects of ketamine and electroconvulsive shock therapy in the rat hippocampus. Int J Neuropsychopharmacol. 16:1885–1892. 2013. View Article : Google Scholar : PubMed/NCBI
11	Dell'Osso B, D'Addario C, Carlotta Palazzo M, Benatti B, Camuri G, Galimberti D, Fenoglio C, Scarpini E, Di Francesco A, Maccarrone M and Altamura AC: Epigenetic modulation of BDNF gene: Differences in DNA methylation between unipolar and bipolar patients. J Affect Disord. 166:330–333. 2014. View Article : Google Scholar : PubMed/NCBI
12	Zucchi FC, Yao Y, Ward ID, Ilnytskyy Y, Olson DM, Benzies K, Kovalchuk I, Kovalchuk O and Metz GA: Maternal stress induces epigenetic signatures of psychiatric and neurological diseases in the offspring. PLoS One. 8:e569672013. View Article : Google Scholar : PubMed/NCBI
13	Murgatroyd C, Wu Y, Bockmühl Y and Spengler D: Genes learn from stress: How infantile trauma programs us for depression. Epigenetics. 5:194–199. 2010. View Article : Google Scholar : PubMed/NCBI
14	Forlani G, Giarda E, Ala U, Di Cunto F, Salani M, Tupler R, Kilstrup-Nielsen C and Landsberger N: The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: Novel hints for Rett syndrome pathogenesis. Hum Mol Genet. 19:3114–3123. 2010. View Article : Google Scholar : PubMed/NCBI
15	Hutchinson AN, Deng JV, Cohen S and West AE: Phosphorylation of MeCP2 at Ser421 contributes to chronic antidepressant action. J Neurosci. 32:14355–14363. 2012. View Article : Google Scholar : PubMed/NCBI
16	Murgatroyd C, Patchev AV, Wu Y, Micale V, Bockmühl Y, Fischer D, Holsboer F, Wotjak CT, Almeida OF and Spengler D: Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat Neurosci. 12:1559–1566. 2009. View Article : Google Scholar : PubMed/NCBI
17	Wada R, Akiyama Y, Hashimoto Y, Fukamachi H and Yuasa Y: miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer. Int J Cancer. 127:1106–1114. 2010. View Article : Google Scholar
18	Klein ME, Lioy DT, Ma L, Impey S, Mandel G and Goodman RH: Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat Neurosci. 10:1513–1514. 2007. View Article : Google Scholar : PubMed/NCBI
19	Im HI, Hollander JA, Bali P and Kenny PJ: MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci. 13:1120–1127. 2010. View Article : Google Scholar : PubMed/NCBI
20	Luo YW, Xu Y, Cao WY, Zhong XL, Duan J, Wang XQ, Hu ZL, Li F, Zhang JY, Zhou M, Dai RP and Li CQ: Insulin-like growth factor 2 mitigates depressive behavior in a rat model of chronic stress. Neuropharmacology. 89:318–324. 2015. View Article : Google Scholar
21	Munno D, Sterpone S, Fania S, Cappellin F, Mengozzi G, Saroldi M, Bechon E and Zullo G: Plasma brain derived neurotrophic factor levels and neuropsychological aspects of depressed patients treated with paroxetine. Panminerva Med. 55:377–384. 2013.
22	Yu H, Wang DD, Wang Y, Liu T, Lee FS and Chen ZY: Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants. J Neurosci. 32:4092–4101. 2012. View Article : Google Scholar : PubMed/NCBI
23	Carballedo A, Amico F, Ugwu I, Fagan AJ, Fahey C, Morris D, Meaney JF, Leemans A and Frodl T: Reduced fractional anisotropy in the uncinate fasciculus in patients with major depression carrying the met-allele of the Val66Met brain-derived neurotrophic factor genotype. Am J Med Genet B Neuropsychiatr Genet. 159B:537–548. 2012. View Article : Google Scholar : PubMed/NCBI
24	Valvassori SS, Budni J, Varela RB and Quevedo J: Contributions of animal models to the study of mood disorders. Rev Bras Psiquiatr. 35(Suppl 2): S121–S131. 2013. View Article : Google Scholar : PubMed/NCBI
25	Xu X, Kozikowski AP and Pozzo-Miller L: A selective histone deacetylase-6 inhibitor improves BDNF trafficking in hippocampal neurons from Mecp2 knockout mice: Implications for Rett syndrome. Front Cell Neurosci. 8:682014. View Article : Google Scholar : PubMed/NCBI
26	Khoshnan A and Patterson PH: Elevated IKKα accelerates the differentiation of human neuronal progenitor cells and induces MeCP2-dependent BDNF expression. PLoS One. 7:e417942012. View Article : Google Scholar
27	Cortés-Mendoza J, Díaz de León-Guerrero S, Pedraza-Alva G and Pérez-Martínez L: Shaping synaptic plasticity: the role of activity-mediated epigenetic regulation on gene transcription. Int J Dev Neurosci. 31:359–369. 2013. View Article : Google Scholar : PubMed/NCBI
28	Lv J, Xin Y, Zhou W and Qiu Z: The epigenetic switches for neural development and psychiatric disorders. J Genet Genomics. 40:339–346. 2013. View Article : Google Scholar : PubMed/NCBI
29	Li H, Zhong X, Chau KF, Williams EC and Chang Q: Loss of activity-induced phosphorylation of MeCP2 enhances synaptogenesis, LTP and spatial memory. Nat Neurosci. 14:1001–1008. 2011. View Article : Google Scholar : PubMed/NCBI
30	Li W, Calfa G, Larimore J and Pozzo-Miller L: Activity-dependent BDNF release and TRPC signaling is impaired in hippocampal neurons of Mecp2 mutant mice. Proc Natl Acad Sci USA. 109:17087–17092. 2012. View Article : Google Scholar : PubMed/NCBI
31	Chang Q, Khare G, Dani V, Nelson S and Jaenisch R: The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron. 49:341–348. 2006. View Article : Google Scholar : PubMed/NCBI
32	Zhou Z, Hong EJ, Cohen S, Zhao WN, Ho HY, Schmidt L, Chen WG, Lin Y, Savner E, Griffith EC, et al: Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron. 52:255–269. 2006. View Article : Google Scholar : PubMed/NCBI
33	Oved K, Morag A, Pasmanik-Chor M, Oron-Karni V, Shomron N, Rehavi M, Stingl JC and Gurwitz D: Genome-wide miRNA expression profiling of human lymphoblastoid cell lines identifies tentative SSRI antidepressant response biomarkers. Pharmacogenomics. 13:1129–1139. 2012. View Article : Google Scholar : PubMed/NCBI
34	Scott HL, Tamagnini F, Narduzzo KE, Howarth JL, Lee YB, Wong LF, Brown MW, Warburton EC, Bashir ZI and Uney JB: MicroRNA-132 regulates recognition memory and synaptic plasticity in the perirhinal cortex. Eur J Neurosci. 36:2941–2948. 2012. View Article : Google Scholar : PubMed/NCBI
35	Shaltiel G, Hanan M, Wolf Y, Barbash S, Kovalev E, Shoham S and Soreq H: Hippocampal microRNA-132 mediates stress-inducible cognitive deficits through its acetylcholinesterase target. Brain Struct Funct. 218:59–72. 2013. View Article : Google Scholar :
36	Abuhatzira L, Makedonski K, Kaufman Y, Razin A and Shemer R: MeCP2 deficiency in the brain decreases BDNF levels by REST/CoREST-mediated repression and increases TRKB production. Epigenetics. 2:214–222. 2007. View Article : Google Scholar : PubMed/NCBI
37	Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J and Zoghbi HY: MeCP2, a key contributor to neurological disease, activates and represses transcription. Science. 320:1224–1229. 2008. View Article : Google Scholar : PubMed/NCBI